IL11 and pulmonary fibrosis: Here, we demonstrate a proof of concept for the design and preclinical use of an inhalable nanoparticulate-mediated RNA interference (RNAi) approach targeting IL11 for inhibition of lung fibrosis progression and enhanced recovery of pulmonary function in a mouse model of bleomycin-induced pulmonary fibrosis (Fig. 1).